Valuation: Lonza Group AG

Capitalization 35.97B 45.62B 38.87B 33.87B 63.08B 4,243B 64.38B 422B 165B 2,038B 171B 168B 7,260B P/E ratio 2026 *
31.4x
P/E ratio 2027 * 26x
Enterprise value 39.27B 49.81B 42.43B 36.97B 68.87B 4,632B 70.28B 461B 180B 2,224B 187B 183B 7,926B EV / Sales 2026 *
5.5x
EV / Sales 2027 * 4.88x
Free-Float
93.86%
Yield 2026 *
1.05%
Yield 2027 * 1.2%

Last Transcript: Lonza Group AG

1 day+1.74%
1 week+0.55%
Current month+2.02%
1 month+3.73%
3 months-6.97%
6 months-2.35%
Current year-4.24%
1 week 502.2
Extreme 502.2
525.8
1 month 454.6
Extreme 454.6
525.8
Current year 454.6
Extreme 454.6
585.6
1 year 454.6
Extreme 454.6
605.2
3 years 308.6
Extreme 308.6
616
5 years 308.6
Extreme 308.6
785.4
10 years 152.8
Extreme 152.8
785.4
Manager TitleAgeSince
Chief Executive Officer 54 01/07/2024
Director of Finance/CFO 54 01/12/2021
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 65 16/04/2014
Director/Board Member 68 16/04/2014
Director/Board Member 66 26/04/2016
Change 5d. change 1-year change 3-years change Capi.($)
+1.74%+0.55%-1.27%-9.27% 45.62B
-1.20%-0.36%+48.65%+31.77% 34.34B
-0.89%+2.25%+26.48%+33.05% 29.46B
-0.97%-3.42%+16.84%-15.01% 28.09B
+0.22%-2.71%+186.40%+369.47% 19.11B
-1.01%+4.38%+66.94%+223.70% 14.78B
+2.31%-6.43%+3,777.83%+3,935.28% 14.25B
-1.59%-0.97%+74.81%+158.73% 14.09B
+0.25%-4.10%+37.01%+4.36% 13.25B
-1.65%+0.51%+181.43%+103.66% 12.42B
Average -0.28%-1.06%+441.51%+483.58% 22.54B
Weighted average by Cap. -0.14%-0.73%+288.60%+316.10%

Financials

2026 *2027 *
Net sales 7.14B 9.06B 7.71B 6.72B 12.52B 842B 12.78B 83.75B 32.77B 404B 33.98B 33.26B 1,441B 8B 10.14B 8.64B 7.53B 14.03B 944B 14.32B 93.83B 36.71B 453B 38.07B 37.26B 1,614B
Net income 1.16B 1.47B 1.25B 1.09B 2.03B 137B 2.07B 13.58B 5.32B 65.6B 5.51B 5.4B 234B 1.4B 1.78B 1.51B 1.32B 2.46B 165B 2.51B 16.45B 6.44B 79.42B 6.67B 6.53B 283B
Net Debt 3.3B 4.18B 3.56B 3.1B 5.78B 389B 5.9B 38.68B 15.13B 187B 15.69B 15.36B 665B 3.04B 3.86B 3.29B 2.86B 5.34B 359B 5.44B 35.69B 13.96B 172B 14.48B 14.17B 614B
Logo Lonza Group AG
Lonza Group AG is one of the world leaders of the contract development and manufacturing of pharmaceutical and biotechnology products. Net sales break down by family of products and services as follows: - biologics and bio-pharmaceuticals (55.9%): microbiological fermentation products, mammalian cell-based bio-pharmaceuticals, monoclonal antibodies, therapeutic proteins, etc.; - synthesis products (24.7%): chemopharmaceutical products, bioconjugates, small molecules, active pharmaceutical ingredients, complex intermediates, etc.; - specialised therapeutic products (15.8%): cell and gene therapies, synthetic therapeutic nucleic acids, oligonucleotides, microbial biological products, etc.; - others (3.6%).
Employees
20,000
Date Price Change Volume
10/04/26 515.00 CHF +1.74% 212,914
09/04/26 506.20 CHF -0.47% 128,291
08/04/26 508.60 CHF +1.11% 193,327
07/04/26 503.00 CHF -1.80% 251,300
02/04/26 512.20 CHF -0.35% 104,065
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
515.00CHF
Average target price
675.78CHF
Spread / Average Target
+31.22%

Quarterly revenue - Rate of surprise